Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.0446
Abstract: Key Points Question Are there differences in the magnitude and durability of neutralizing antibody (nAb) responses against SARS-CoV-2 variants of concern (VOCs) according to the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines? Findings In this comparative…
read more here.
Keywords:
mrna;
variants concern;
immunocompromised patients;
nab responses ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Virology"
DOI: 10.1128/jvi.00404-21
Abstract: Widespread immunity to SARS-CoV-2 will be necessary to end the COVID-19 pandemic. NAb responses are a critical component of immunity that can be stimulated by natural infection as well as vaccines. ABSTRACT Emerging SARS-CoV-2 variants…
read more here.
Keywords:
cov variants;
cross neutralization;
early pandemic;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Virology"
DOI: 10.1128/jvi.01907-20
Abstract: The elicitation of sustained neutralizing antibody (nAb) responses against diverse ebolavirus strains remains a high priority for the vaccine field. The most clinically advanced rVSV-ZEBOV vaccine could elicit moderate nAb responses against only one ebolavirus…
read more here.
Keywords:
immunization;
ebolavirus;
neutralizing antibody;
interface ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "mBio"
DOI: 10.1128/mbio.00429-21
Abstract: Self-assembling protein nanoparticles (NPs) presenting BG505 envelope (Env) trimers can elicit tier 2 HIV-1-neutralizing antibody (NAb) responses more effectively than soluble trimers. In the present study, monoclonal NAbs were isolated from previously immunized mice and…
read more here.
Keywords:
gp41 stabilized;
bg505 env;
envelope;
env ... See more keywords